ArticleFrontiers in oncology2023
Tocilizumab (monoclonal anti-IL-6R antibody) reverses anlotinib resistance in osteosarcoma.
Jiuhui Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papertrialcites it
ArticleFrontiers in oncology2023
Jiuhui Xu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.